DG Research and Innovation

DG Research and Innovation
Name	Directorate-General for Research and Innovation
Native name	Directorate-General for Research and Innovation
Formation	1960s
Type	Directorate-General
Headquarters	Brussels
Parent organization	European Commission

Contents

DG Research and Innovation

DG Research and Innovation is the directorate-general of the European Commission responsible for shaping European Union research policy, coordinating scientific programs and distributing research funding across member France, Germany, Italy, Spain and other European Economic Area participants. It steers initiatives that connect institutions such as the European Research Council, Horizon 2020, Horizon Europe and agencies like the Innovation and Networks Executive Agency to stakeholders including the European Parliament, European Council and national research ministries in Poland, Sweden and Netherlands.

History and mandate

The formation traces to post-war efforts involving the OEEC and early European Coal and Steel Community research collaboration, evolving through milestones such as the Single European Act and the Treaty of Maastricht to adopt a consolidated mandate for cross-border innovation and technology policy alongside bodies like the European Investment Bank and Joint Research Centre. Mandates were elaborated under successive Framework Programmes including FP6, FP7, leading to modern frameworks like Horizon 2020 and Horizon Europe. Legal bases reference treaties negotiated in Rome and policy shifts debated in the European Commission and approved by the European Parliament.

The Directorate-General reports within the European Commission hierarchy and interacts with Commissioners appointed by the European Council and confirmed by the European Parliament. Its internal directorates coordinate with the European Research Council, European Innovation Council, the European Institute of Innovation and Technology, and networks such as the European Research Area. Leadership has included Directors-General nominated through Commission appointments akin to Commissioners from member states such as Belgium, Ireland, Austria and Greece, and works alongside advisory boards with representatives from institutions like the Max Planck Society, CNRS, CERN and Fraunhofer Society.

Policy development aligns with strategic frameworks including the European Green Deal, Digital Europe Programme, and regulatory acts debated in the Council of the European Union. Programs cover thematic priorities connected to actors like University of Oxford, Université PSL, Karolinska Institute, and industrial partners such as Siemens, Airbus, Philips and BASF. Policy instruments incorporate open science mandates, ethical guidelines drawn from stakeholder consultations including World Health Organization experts, and alignment with standards from the International Organization for Standardization and collaborations with the European Medicines Agency.

Funding mechanisms channel grants through competitive calls managed under frameworks like Horizon Europe, distributed to beneficiaries including ETH Zurich, Imperial College London, Université Paris-Saclay, Politecnico di Milano and consortia involving Nokia, Ericsson and TotalEnergies. Instruments include grants, procurement, prizes (in the spirit of the Nobel Prize and European Inventor Award), and partnerships with financing entities such as the European Investment Bank and the European Bank for Reconstruction and Development. Peer review panels comprise experts from organizations like EMBO, Royal Society, Deutsche Forschungsgemeinschaft and national academies.

Major initiatives have included large-scale undertakings tied to research infrastructures like CERN, ITER, EMBL, and projects spanning climate, health and digital transitions aligned with Copernicus Programme, Galileo (satellite navigation), and multinational consortia behind projects with partners such as Pfizer, AstraZeneca, Bayer and research units at Harvard University through international cooperation agreements. Innovation acceleration initiatives include support for European Institute of Innovation and Technology Knowledge and Innovation Communities alongside piloting missions resembling Mission Innovation targets.

International cooperation extends to bilateral and multilateral arrangements with entities such as the United States, Japan, Canada, China (People's Republic of China), India, South Africa and organizations including the United Nations Educational, Scientific and Cultural Organization, Organisation for Economic Co-operation and Development and the World Health Organization. Collaborative frameworks exist with regional bodies like the African Union, Association of Southeast Asian Nations, and research networks such as OpenAIRE, GÉANT and the European Research Area partnerships with national funding agencies such as The Swedish Research Council, ANR (France), National Science Centre (Poland) and Research Councils UK predecessors.

Evaluations by the Court of Auditors and independent reviewers compare programme outcomes against objectives set by the European Parliament and the European Commission, measuring impacts on innovation ecosystems in Lithuania, Romania and Portugal as well as flagship research outputs cited by Nature (journal), Science (journal), and patent filings to offices like the European Patent Office. Controversies have arisen over topics involving allocation transparency contested in hearings before the European Ombudsman, disputes over ethical review processes linked to biomedical projects involving GAVI Alliance partners, and geopolitical sensitivities in collaborations with Russia and People's Republic of China. Debates continue within bodies such as the Council of the European Union and policy forums attended by representatives from European Trade Union Confederation and industry associations.

Category:European Commission directorates-general Category:Science policy